Rebien Pharma Consult ApS
CVR 44760479 · Private limited company (ApS) · Active · Low risk
Rebien Pharma Consult ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 1 annual report has been published. The latest annual report (30 Jun 2025) shows equity of DKK 209k and a net result of DKK 169k. CEO: Mette Correl Rebien.
Bankruptcy risk for Rebien Pharma Consult ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44760479
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Rosenvængets Allé 17, 2.
2100 København Ø - Municipality
- København
- Industry
- Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 58.9% |
| Current ratio | 243% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 10 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 217k |
| Net profit | DKK 169k |
| Equity | DKK 209k |
| Total assets | DKK 355k |
| Cash | DKK 175k |
| Short-term debt | DKK 146k |
| Tax owed | DKK 48k |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 5 Apr 2024 – 30 Jun 2025 | 161 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mette Correl Rebien | Current | |
| Owner (100%) | OLESEN SHIPPING ApS | Current | |
| Founder | OLESEN SHIPPING ApS | Current |
The CEOs' other companies
Mette Correl Rebien – 1 other companies
- IVERSEN OG JACOBSEN A/S Active
Address history (0 moves)
| Rosenvængets Allé 17, 2., 2100 København Ø |
Other companies at the same address
- Østerbro ADM. ApS Bankrupt
- Borups Alle 138 ApS Active
- Gullev & Co ApS Active
- Gullev Holding ApS Active
- HRYMFAXE ApS Active
- IVERSEN OG JACOBSEN A/S Active
- JS LYS ApS Active
- OLESEN SHIPPING ApS Active
- VERONA BAGERIET ApS Active
- Vita Verde ApS Active
Similar companies in København
- PROXIMA INTERNATIONAL ApS København Ø
- TALODOM ApS København K
- KASI HOLDING ApS København K
- MOGENSEN A/S København S
- COBO Consult ApS København N
- PA CONSULTING GROUP A/S Nordhavn
- A.T. KEARNEY DENMARK A/S København K
- J&P Invest, Kbh. ApS København K
- RAMBØLL MANAGEMENT CONSULTING A/S København S
- SELSKABET AF DEN 19.10.2026 A/S København Ø
- Asante Management ApS København SV
- Digital Transformation Capital Partners Denmark ApS København Ø
Questions and answers about Rebien Pharma Consult ApS
Has Rebien Pharma Consult ApS gone bankrupt?
No, Rebien Pharma Consult ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Rebien Pharma Consult ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Rebien Pharma Consult ApS?
Mette Correl Rebien is the CEO of Rebien Pharma Consult ApS.
When was Rebien Pharma Consult ApS founded?
Rebien Pharma Consult ApS was founded on 5 April 2024.
What is the equity of Rebien Pharma Consult ApS?
Equity was DKK 209k according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.